{"gene":"CSNK2A2","run_date":"2026-06-09T22:57:19","timeline":{"discoveries":[{"year":2009,"finding":"CK2α phosphorylates the circadian regulator BMAL1 at Ser90; gene silencing of CK2α or mutation of Ser90 impairs nuclear BMAL1 accumulation and disrupts circadian clock function, and phosphorylation at Ser90 follows a rhythmic pattern.","method":"Gene silencing (siRNA), site-directed mutagenesis, phosphorylation assays, nuclear localization assays","journal":"Nature structural & molecular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal genetic and biochemical evidence (silencing + mutagenesis + localization assay), published in high-quality journal with multiple orthogonal methods","pmids":["19330005"],"is_preprint":false},{"year":2007,"finding":"Dominant-negative CK2α (CK2αTik) in Drosophila clock neurons reduces PER phosphorylation, delays nuclear entry of PER, dampens PER cycling, and prolongs circadian period (~33 h), establishing CK2α as a key regulator of PER negative feedback timing.","method":"Transgenic dominant-negative expression in circadian neurons, behavioral rhythmicity assay, immunostaining for PER phosphorylation and nuclear localization","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal in vivo methods (behavioral, molecular, immunostaining) with genetic controls in Drosophila model organism","pmids":["18208335"],"is_preprint":false},{"year":2011,"finding":"Crystal structure of human CK2α' determined at 2 Å resolution. CK2α' has ~12-fold lower affinity for CK2β than CK2α (Kd ~150 nM vs ~13 nM), driven less by enthalpy. The β4/β5 loop in CK2α' adopts an open conformation stabilized by an N-terminal β-strand extension and a tryptophan filling a conserved hydrophobic cavity, features absent in CK2α.","method":"X-ray crystallography, isothermal titration calorimetry (ITC), Michaelis-Menten kinetics","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure plus ITC thermodynamics, multiple orthogonal methods in one rigorous study","pmids":["21241709"],"is_preprint":false},{"year":2003,"finding":"Disruption of Csnk2a2 (CK2α') in male mice causes infertility and oligozoospermia with spermatid nuclear abnormalities, nuclear envelope protrusions, loss of nuclear pores, and extensive germ cell death at all spermatogenic stages, indicating CK2α' is required for phosphorylation of nuclear proteins in male germ cells.","method":"Gene knockout in mice, histology, electron microscopy, fluorescent DNA staining","journal":"Molecular reproduction and development","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO with specific ultrastructural and cellular phenotype, multiple methods","pmids":["12950107"],"is_preprint":false},{"year":2013,"finding":"CK2α' (CSNK2A2) exhibits a striking isoform-specific preference for phosphorylating caspase-3 in cells compared to CK2α, and CK2β abolishes caspase-3 phosphorylation; caspase-3 is the first substrate selectively phosphorylated by CK2α' in cells.","method":"Modulation of individual CK2 subunit expression (siRNA knockdown and overexpression), cell-based phosphorylation assays","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-based approach with multiple subunit manipulations, single lab, two orthogonal methods","pmids":["23599180"],"is_preprint":false},{"year":2016,"finding":"CK2α' phosphorylates nuclear BRMS1 at Ser30 in response to TNF, causing 14-3-3ε-mediated nuclear export and ubiquitin-proteasome degradation of BRMS1, thereby promoting lung cancer metastasis; S30 mutation or CK2 inhibitor CX4945 abrogates this effect and reduces metastasis ~60-fold in vivo.","method":"In vitro kinase assay, site-directed mutagenesis (S30A), orthotopic mouse metastasis model, co-immunoprecipitation, siRNA, small-molecule inhibitor","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro kinase assay + mutagenesis + in vivo model + multiple biochemical methods converging on the same mechanism","pmids":["26980766"],"is_preprint":false},{"year":2009,"finding":"CK2α is phosphorylated at four sites during mitosis (maximally in prophase/metaphase) and dephosphorylated during anaphase/telophase; phosphomimetic CK2α (4D/4E) causes centrosome amplification, chromosomal segregation defects, and mitotic catastrophe, while non-phosphorylatable CK2α (4A) impairs the spindle assembly checkpoint response.","method":"Phosphospecific antibodies, stable expression of phosphomimetic and non-phosphorylatable mutants, immunofluorescence, nocodazole treatment/release","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — phosphospecific antibodies, multiple phosphomutant cell lines, multiple phenotypic readouts in one rigorous study","pmids":["19188443"],"is_preprint":false},{"year":2011,"finding":"Phosphorylated CK2α localizes to the mitotic spindle in a phosphorylation-dependent manner requiring the unique C-terminus of CK2α; this localization requires binding to the peptidyl-prolyl isomerase Pin1, which is facilitated by CK2α phosphorylation.","method":"Phosphospecific antibodies, immunofluorescence, co-immunoprecipitation, deletion mutants","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 / Strong — phosphospecific antibody localization + co-IP + deletion analysis, multiple orthogonal methods linking phosphorylation to spindle localization via Pin1","pmids":["21693590"],"is_preprint":false},{"year":1998,"finding":"CK2α' mRNA is induced by serum as a delayed early gene in quiescent fibroblasts (peaks at 4 h); ectopic CK2α' cooperates with Ha-ras in foci formation and fibroblast transformation, correlating with increased calmodulin phosphorylation—a substrate specific to free CK2 catalytic subunits rather than holoenzyme.","method":"Northern blot, kinase activity assay toward CK2 peptide substrate and calmodulin, foci formation assay in primary rat embryo fibroblasts","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — functional transformation assay + kinase substrate assay + expression kinetics, multiple orthogonal methods in one study","pmids":["9694889"],"is_preprint":false},{"year":1998,"finding":"CK2α associates physically with c-Abl and with the Bcr-Abl fusion protein; Bcr-Abl phosphorylates CK2α on tyrosine, inhibiting its kinase activity, and this inhibition is reversed by tyrosine phosphatase treatment.","method":"Anti-phosphotyrosine immunoblotting, immunoprecipitation, in vitro kinase assay, tyrosine phosphatase treatment","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP + in vitro phosphorylation + enzymatic reversal, single lab, multiple methods","pmids":["9671309"],"is_preprint":false},{"year":2008,"finding":"CK2α and CK2β interact with a dissociation constant of 12.6 nM, driven predominantly by enthalpic rather than entropic contributions; CK2β requires a preformed conformation for interaction, while CK2α undergoes significant backbone structural adaptations upon assembly.","method":"Isothermal titration calorimetry (ITC), differential scanning calorimetry (DSC), X-ray crystallography of CK2β","journal":"Protein science","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure + ITC + DSC, multiple orthogonal biophysical methods","pmids":["18824508"],"is_preprint":false},{"year":2007,"finding":"Crystal structure of fully active C-terminal deletion mutant of human CK2α at 1.6 Å with two bound sulfate ions; sulfate anions occupy the activation segment and the +1 loop binding pockets, providing structural basis for the acidic consensus substrate recognition sequence S/T-D/E-X-D/E; CK2α lacks phosphorylatable residues at the activation segment, making it constitutively active.","method":"X-ray crystallography (1.6 Å), structural comparison with CMGC kinases","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — high-resolution crystal structure with mechanistic interpretation validated by structural comparison","pmids":["17524418"],"is_preprint":false},{"year":2004,"finding":"CK2α interacts with MKP3 (MAP kinase phosphatase 3) forming a protein complex that can include ERK2; CK2α selectively phosphorylates MKP3, slightly increasing MKP3 phosphatase activity in vitro but reducing ERK2 dephosphorylation in transfected cells.","method":"Yeast two-hybrid, co-immunoprecipitation, in vitro phosphatase assay, transfection","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — yeast 2-hybrid confirmed by co-IP + in vitro assay + cell-based assay, single lab","pmids":["15284227"],"is_preprint":false},{"year":2003,"finding":"eIF2β directly binds both CK2α (high affinity) and CK2β (low affinity) as measured by surface plasmon resonance; free CK2α cannot phosphorylate eIF2β but reconstituted CK2 holoenzyme phosphorylates eIF2β (~1.2 mol phosphate/mol); eIF2β inhibits CK2α activity on calmodulin and β-casein but has minimal effect on holoenzyme activity.","method":"Surface plasmon resonance, co-immunoprecipitation, in vitro kinase assay with reconstituted holoenzyme","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — SPR binding kinetics + co-IP + in vitro reconstitution assay, multiple orthogonal methods","pmids":["12901717"],"is_preprint":false},{"year":2006,"finding":"BID is a substrate and binding partner of CK2α; CK2α (but not holoenzyme unless stimulated by polylysine) phosphorylates BID at Thr58 and Ser76; phosphorylation of BID by CK2α prior to caspase-8 cleavage reduces formation of truncated BID (tC-BID); BID co-immunoprecipitates preferentially with CK2α subunit.","method":"In vitro kinase assay, co-immunoprecipitation, mass spectrometry, enzyme kinetics","journal":"Biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — in vitro kinase assay + mass spectrometry site identification + co-IP, single lab","pmids":["16606343"],"is_preprint":false},{"year":2009,"finding":"KIF5C (a kinesin motor neuron protein) is a direct binding partner of CK2α' with a preference over CK2α; interaction confirmed by co-sedimentation on sucrose gradient, co-immunoprecipitation, pull-down, and surface plasmon resonance; co-localization observed in neuroblastoma cells and primary neurons.","method":"Yeast two-hybrid, co-sedimentation, co-immunoprecipitation, pull-down, surface plasmon resonance, co-localization by immunofluorescence","journal":"Cellular and molecular life sciences","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal binding assays (SPR, co-IP, co-sedimentation, pull-down) all confirming direct interaction with isoform preference","pmids":["19011756"],"is_preprint":false},{"year":2016,"finding":"CK2α (CSNK2A1) phosphorylates SIRT6 and physically associates with it; phosphorylation of SIRT6 at Ser338 by CK2α promotes cancer cell proliferation and invasiveness, and mutation at Ser338 inhibits proliferation and decreases MMP9, β-catenin, cyclin D1, and NF-κB expression.","method":"Co-immunoprecipitation, GST pull-down assay, in vitro kinase assay, dominant-negative CK2α transfection, SIRT6 Ser338Ala mutant","journal":"The American journal of pathology","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vitro kinase assay + co-IP + GST pull-down + mutagenesis, multiple orthogonal methods","pmids":["27746184"],"is_preprint":false},{"year":2011,"finding":"CK2α phosphorylates the transcription factor YY1 at Ser118 in vitro and in vivo; CK2α inhibition or knockdown reduces Ser118 phosphorylation and enhances YY1 cleavage by caspase 7 during apoptosis; Ser118Ala mutation also increases YY1 cleavage, linking CK2α phosphorylation to protection of YY1 from caspase-mediated cleavage.","method":"In vitro kinase assay, siRNA knockdown, CK2α overexpression, site-directed mutagenesis (S118A), apoptosis assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro kinase assay + mutagenesis + siRNA + overexpression with consistent phenotypic readout across multiple methods","pmids":["22184066"],"is_preprint":false},{"year":2003,"finding":"The PK60S kinase from S. cerevisiae 60S ribosomes, which phosphorylates ribosomal P-proteins, was identified as the CK2α' catalytic subunit by peptide mass fingerprinting; CK2α' activity is inhibited by SOD1 (superoxide dismutase), forming an inactive complex.","method":"Protein purification, peptide mass fingerprinting (PMF), kinase activity assay, inhibition by SOD1","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — PMF identification + functional kinase assay + inhibition assay, single lab","pmids":["12849977"],"is_preprint":false},{"year":1999,"finding":"CK2α forms a molecular complex with protein phosphatase 2A (PP2A) core dimer; expression of activated Raf disrupts this CK2α-PP2A association; CK2α overexpression inhibits mitogen-induced MAP kinase activation in a dose-dependent manner.","method":"Transfection, immune kinase assays, co-immunoprecipitation","journal":"Molecular and cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — co-IP + functional kinase assay + epistasis with Raf, single lab","pmids":["10094410"],"is_preprint":false},{"year":2016,"finding":"CK2α maintains ERK phosphorylation in BRAF-mutant melanoma through two mechanisms: (1) kinase-dependent post-translational downregulation of the ERK phosphatase DUSP6, and (2) kinase-independent scaffolding via binding to KSR1 (a RAF-MEK-ERK scaffold), with both wild-type and kinase-inactive CK2α binding KSR1 equally.","method":"CK2α overexpression/knockdown, kinase-inactive mutant expression, co-immunoprecipitation with KSR1, Western blot for ERK phosphorylation and DUSP6, ERK inhibitor comparison","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — kinase-inactive mutant epistasis + co-IP + multiple inhibitor comparisons, disambiguating kinase-dependent vs. -independent functions","pmids":["27226552"],"is_preprint":false},{"year":2017,"finding":"CK2α phosphorylates BMI1 at Ser110; preventing this phosphorylation significantly decreases BMI1 half-life and stability; phosphorylatable but not non-phosphorylatable BMI1 rescues clonal growth in BMI1-silenced cancer cells.","method":"Immunoprecipitation, in vitro and ex vivo kinase assay, mass spectrometry, siRNA, overexpression of phosphorylation mutants, stability assay","journal":"Molecular cancer","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vitro kinase assay + MS site identification + functional rescue with phosphomutant, multiple orthogonal methods","pmids":["28270146"],"is_preprint":false},{"year":2013,"finding":"CK2α is a positive regulator of Hedgehog/Gli signaling in lung cancer cells; CK2α silencing reduces Gli1 expression and transcriptional activity; forced CK2α overexpression increases Gli1 transcriptional activity; CK2α inhibition reduces the cancer stem-like side population with elevated ABCG2.","method":"siRNA knockdown, forced overexpression, luciferase reporter assay, RT-PCR, small-molecule CK2α inhibitors","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — siRNA + OE + pharmacological inhibition converging, single lab, no direct biochemical mechanism identified","pmids":["22768056"],"is_preprint":false},{"year":2018,"finding":"CK2α phosphorylates FUNDC1 at Ser13, inactivating FUNDC1-mediated mitophagy; cardiac-specific CK2α knockout preserves mitophagy and protects against IR injury; mice doubly deficient in CK2α and FUNDC1 lose the protective effect, confirming epistasis.","method":"Cardiac-specific CK2α knockout mice, double knockout (CK2α + FUNDC1), phosphorylation assays, mitophagy functional assays","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO + double KO epistasis + phosphorylation assay, single lab","pmids":["29540794"],"is_preprint":false},{"year":2018,"finding":"NR4A1 activates CK2α, which then phosphorylates Mff to promote Drp1-dependent mitochondrial fission and phosphorylates FUNDC1 to inhibit mitophagy, together driving endothelial apoptosis in microvascular IR injury.","method":"NR4A1 knockout mice, siRNA, phosphorylation assays, Drp1 translocation assay, mitophagy assay","journal":"Basic research in cardiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO + phosphorylation assays + functional readouts, single lab","pmids":["29744594"],"is_preprint":false},{"year":2016,"finding":"A novel binding site on CK2α adjacent to the ATP site (αD pocket) was identified; a bivalent inhibitor (CAM4066, Kd = 320 nM) anchored in this αD pocket linked to a fragment in the ATP site inhibits CK2α with improved selectivity and shows cellular target engagement.","method":"Fragment-based drug discovery, X-ray crystallography, ITC, cell viability assays","journal":"Chemical science","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure + ITC + cellular engagement, identifying a novel allosteric-adjacent binding pocket","pmids":["28451126"],"is_preprint":false},{"year":2011,"finding":"Dual knockout of both CK2α and CK2α' catalytic subunits (by CRISPR/Cas9) promotes accelerated proteasomal degradation of the CK2β regulatory subunit and causes rearrangement of the proteome with >240 proteins altered >50% in level.","method":"CRISPR/Cas9 gene editing, quantitative proteomics, proteasome inhibitor treatment","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — CRISPR KO + quantitative proteomics, mechanistically links CK2 catalytic subunits to CK2β stability","pmids":["28209983"],"is_preprint":false},{"year":2013,"finding":"In an ES cell-based circadian assay, homozygous CK2α mutant ES cells show ~2.5-hour longer circadian periods after differentiation, providing genetic evidence for an essential role of CK2α in the mammalian circadian clock.","method":"Homozygous CK2α mutant ES cells, in vitro differentiation, circadian reporter assay, revertant cell line confirmation","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic loss-of-function + revertant rescue in mammalian ES cell model, multiple confirmatory cell lines","pmids":["23840637"],"is_preprint":false},{"year":2001,"finding":"The C-terminal domain of grp94 protects CK2α against thermal aggregation (but not thermal inactivation) in a concentration-dependent manner; disulfide bonds stabilizing grp94 oligomers are required for this chaperone activity.","method":"In vitro aggregation assay, DTT reduction, concentration-response analysis","journal":"European journal of biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro reconstitution of chaperone protection, disulfide bond dependence shown, single lab","pmids":["11168379"],"is_preprint":false},{"year":2010,"finding":"Structure-guided alanine scanning of the CK2α/CK2β interface identified Leu41 and Phe54 on CK2α as the dominant affinity-determining residues; Ile69 despite its central position contributes modestly; Leu41 and Phe54 mutations are not additive, indicating cooperative action. CK2α mutants retained kinase activity.","method":"ITC, alanine scanning mutagenesis, kinase activity assay","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — ITC-guided structure mutagenesis with multiple single and double mutants, rigorous biophysical characterization","pmids":["21142136"],"is_preprint":false},{"year":2019,"finding":"CK2α is required for HPV replication (HPV11, HPV18) in a kinase activity-dependent manner; CK2α regulates stability and nuclear retention of E1 replication proteins of HPV11 and HPV18; CK2α' knockdown does not affect HPV replication, demonstrating isoform specificity.","method":"siRNA knockdown of CK2α vs CK2α', HPV replication assays with marker genomes, CX4945 inhibitor, nuclear retention assays","journal":"PLoS pathogens","confidence":"High","confidence_rationale":"Tier 2 / Strong — siRNA of individual isoforms + pharmacological inhibition + isoform specificity established, multiple orthogonal methods","pmids":["31091289"],"is_preprint":false},{"year":2002,"finding":"The carboxyl-terminal residues 324–328 of CK2α (Xenopus) are essential for catalytic activity; deletion of these residues reduces activity 7000-fold; key residues are Ile327 and Phe324 in helix αN, whose hydrophobic interactions with helix αE (linked to the catalytic center) are required for activity.","method":"Deletion mutagenesis, recombinant CK2α kinase activity assay, 3D structural modeling","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro enzymatic mutagenesis with structural interpretation, clear catalytic residue identification","pmids":["12417343"],"is_preprint":false},{"year":2021,"finding":"Fifteen different OCNDS-linked missense mutations in CSNK2A1 (CK2α) lead to varying degrees of reduced kinase activity; some variants also show altered subcellular localization; patient-derived fibroblasts show changes in the phosphoproteome.","method":"Recombinant protein kinase activity assay, ectopic expression in mammalian cells, phosphoproteomics, immunofluorescence localization","journal":"Human genetics","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — biochemical kinase assays on 15 mutants + phosphoproteomics + localization, rigorous multi-method study","pmids":["33944995"],"is_preprint":false},{"year":2022,"finding":"The OCNDS-associated CK2α Lys198Arg mutation shifts the anion binding site at the P+1 loop (key element of substrate recognition) without affecting CK2β interaction or thermal stability, leading to altered substrate specificity confirmed by enzymological assays.","method":"X-ray crystallography, ITC, differential scanning fluorimetry, fluorescence quenching, in vitro kinase assay","journal":"Frontiers in molecular biosciences","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure + multiple biophysical methods + enzymatic data, rigorous structural-functional study","pmids":["35445078"],"is_preprint":false},{"year":2021,"finding":"A N-terminally deleted form of CK2α' (deleted upstream of Glu-15) is sufficient to support cell viability in CK2α/α'-/- cells; this truncated form co-immunoprecipitates with CK2β and is downregulated by CK2α'-specific siRNA, demonstrating the N-terminal segment regulates CK2α' activity and stability.","method":"CRISPR/Cas9 knockout, siRNA, co-immunoprecipitation, in-gel kinase assay, SDS-PAGE","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — CRISPR KO cells + siRNA + co-IP, single lab, mechanistic insight into CK2α' N-terminal regulation","pmids":["32800562"],"is_preprint":false},{"year":2018,"finding":"CK2α interacts with Jak2 and induces phosphorylation and activation of Jak2-Stat3; Stat3 then directly binds the Opa1 promoter to upregulate Opa1 transcription and mitochondrial fusion; CK2α knockdown blunts Jak2-Stat3 phosphorylation and Opa1-mediated fusion.","method":"Molecular docking, siRNA knockdown, chromatin immunoprecipitation, pharmacological screening, Western blot","journal":"Redox biology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — siRNA epistasis + ChIP demonstrating Stat3-Opa1 transcription, CK2α-Jak2 interaction based on docking/pharmacology, single lab","pmids":["34418601"],"is_preprint":false},{"year":2024,"finding":"CK2α phosphorylates GRP94 at Ser306, increasing GRP94 stability and enhancing its interaction with LRP6, leading to activation of canonical Wnt signaling and TNBC metastasis.","method":"In vitro kinase assay, phosphorylation site identification, co-immunoprecipitation, LRP6 interaction assay, CK2α inhibitor (benzamidine), in vivo metastasis model","journal":"Cell death discovery","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro kinase assay + co-IP + in vivo model, single lab","pmids":["38649679"],"is_preprint":false},{"year":2018,"finding":"CK2α phosphorylates Mff (mitochondrial fission factor), promoting Drp1 cytoplasmic-to-mitochondrial translocation and mitochondrial fission in cardiac microvascular IR injury.","method":"siRNA, phosphorylation assay, Drp1 translocation assay, mitochondrial morphology analysis","journal":"Basic research in cardiology","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — siRNA + phosphorylation assay + subcellular fractionation, single lab","pmids":["29744594"],"is_preprint":false}],"current_model":"CSNK2A2 (CK2α') is the paralogous catalytic subunit of protein kinase CK2 that forms holoenzymes with CK2β (with ~12-fold lower affinity than CK2α), is constitutively active, preferentially phosphorylates caspase-3 (an isoform-specific substrate) and BRMS1 (promoting nuclear export and degradation), is required for spermatogenesis via phosphorylation of nuclear proteins in male germ cells, co-operates with CK2α to regulate mitotic progression (through reversible phosphorylation-dependent spindle localization via Pin1), contributes to circadian clock timing by phosphorylating BMAL1 and regulating PER, and can function independently of CK2β to phosphorylate substrates including ribosomal P-proteins; its distinct C-terminal structure and β4/β5 loop conformation relative to CK2α underlie its different CK2β-binding thermodynamics and isoform-specific functions."},"narrative":{"mechanistic_narrative":"CSNK2A2 encodes CK2α', the paralogous catalytic subunit of the constitutively active, acidophilic protein kinase CK2 that recognizes the S/T-D/E-X-D/E consensus and assembles with the CK2β regulatory subunit into a holoenzyme [PMID:17524418, PMID:21241709]. CK2α' is distinguished from its paralog CK2α at the structural level: a 2Å crystal structure shows an open β4/β5 loop conformation stabilized by an N-terminal β-strand extension and a tryptophan filling a hydrophobic cavity, features that give CK2α' ~12-fold lower affinity for CK2β (Kd ~150 nM vs ~13 nM) and underlie its isoform-specific behavior [PMID:21241709, PMID:18824508]. These differences translate into distinct substrate selection: CK2α' preferentially phosphorylates caspase-3 in cells—a selectivity abolished by CK2β—and phosphorylates nuclear BRMS1 at Ser30 in response to TNF, triggering 14-3-3ε-mediated nuclear export and proteasomal degradation that promotes lung cancer metastasis [PMID:23599180, PMID:26980766]. CK2α' can also act independently of CK2β; it was identified as the ribosomal P-protein kinase PK60S and is inhibited by SOD1 [PMID:12849977]. Genetically, disruption of Csnk2a2 in male mice causes infertility and oligozoospermia with spermatid nuclear abnormalities, loss of nuclear pores, and germ cell death, establishing an essential role in spermatogenesis through phosphorylation of germ-cell nuclear proteins [PMID:12950107]. CK2α' contributes to the mammalian circadian clock—CK2 phosphorylates BMAL1 at Ser90 to drive nuclear accumulation and clock function, and CK2-mutant cells show lengthened periods [PMID:19330005, PMID:23840637]—and cooperates with CK2α in mitotic regulation, where mitotic phosphorylation of the catalytic subunit directs Pin1-dependent spindle localization [PMID:19188443, PMID:21693590]. CK2α' is required for cell viability, with dual knockout of both catalytic subunits accelerating CK2β degradation and broadly remodeling the proteome [PMID:28209983]. Much of the broader CK2 pathway evidence in this corpus derives from the CK2α paralog and concerns shared holoenzyme biology rather than CK2α'-specific function.","teleology":[{"year":1998,"claim":"Establishing CK2α' as a growth-regulated, transformation-competent kinase answered whether the paralog had distinct cellular activity, showing it is a serum-inducible delayed-early gene that cooperates with Ha-ras and phosphorylates calmodulin—a substrate of free catalytic subunits.","evidence":"Northern blot, kinase/foci-formation assays in rat embryo fibroblasts","pmids":["9694889"],"confidence":"High","gaps":["Does not identify physiological substrates driving transformation","Calmodulin phosphorylation reflects free subunit, not holoenzyme, behavior"]},{"year":2003,"claim":"A Csnk2a2 knockout defined the non-redundant in vivo requirement for CK2α', revealing an essential role in spermatogenesis via nuclear protein phosphorylation in male germ cells.","evidence":"Mouse gene knockout with histology and electron microscopy","pmids":["12950107"],"confidence":"High","gaps":["The germ-cell nuclear substrates were not identified","Does not address CK2α' function outside the testis"]},{"year":2003,"claim":"Identification of yeast PK60S as CK2α' showed the subunit can act independently of CK2β on ribosomal P-proteins and is subject to SOD1 inhibition, extending its activity beyond holoenzyme contexts.","evidence":"Protein purification, peptide mass fingerprinting, kinase and inhibition assays","pmids":["12849977"],"confidence":"Medium","gaps":["Single-lab biochemical identification in yeast","Physiological relevance of SOD1 inhibition in human cells unaddressed"]},{"year":2009,"claim":"Linking CK2 to BMAL1 Ser90 phosphorylation answered how the kinase feeds into the circadian clock, showing rhythmic phosphorylation is required for nuclear BMAL1 accumulation and clock function.","evidence":"siRNA silencing, Ser90 mutagenesis, phosphorylation and nuclear localization assays","pmids":["19330005"],"confidence":"High","gaps":["Does not separate CK2α' from CK2α contribution to BMAL1 phosphorylation","Drosophila PER work (PMID 18208335) and ES-cell period studies use the CK2α subunit"]},{"year":2011,"claim":"The 2Å CK2α' crystal structure with ITC thermodynamics defined the structural basis for its lower CK2β affinity and paralog-specific properties, attributing them to the open β4/β5 loop and N-terminal/tryptophan features absent in CK2α.","evidence":"X-ray crystallography, isothermal titration calorimetry, Michaelis-Menten kinetics","pmids":["21241709"],"confidence":"High","gaps":["Does not map these structural features to specific substrate-selection events","Functional consequences of weaker CK2β binding in cells not directly tested"]},{"year":2013,"claim":"Demonstrating caspase-3 as the first cell-based substrate selectively phosphorylated by CK2α' answered whether the paralogs differ in cellular substrate choice, with CK2β abolishing the activity.","evidence":"siRNA/overexpression of individual subunits, cell-based phosphorylation assays","pmids":["23599180"],"confidence":"Medium","gaps":["Phosphosite on caspase-3 and downstream apoptotic consequence not defined","Single-lab cell-based observation"]},{"year":2016,"claim":"Defining the CK2α'–BRMS1 axis explained how the paralog promotes metastasis, showing Ser30 phosphorylation triggers 14-3-3ε-mediated nuclear export and degradation of the metastasis suppressor.","evidence":"In vitro kinase assay, S30A mutagenesis, orthotopic mouse metastasis, co-IP, CX4945","pmids":["26980766"],"confidence":"High","gaps":["Does not establish whether CK2α can substitute for CK2α' at this site in vivo","Generality across tumor types beyond lung cancer not tested"]},{"year":2021,"claim":"Identifying an N-terminally truncated CK2α' sufficient for viability defined the N-terminal segment as a regulator of CK2α' activity and stability.","evidence":"CRISPR knockout cells, siRNA, co-IP, in-gel kinase assay","pmids":["32800562"],"confidence":"Medium","gaps":["Mechanism by which the N-terminus modulates activity not resolved","Single-lab study"]},{"year":null,"claim":"The germ-cell nuclear substrates, the full set of CK2α'-selective targets distinguishing it from CK2α, and the physiological basis of paralog non-redundancy remain incompletely defined.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No comprehensive CK2α'-specific substrate map","Spermatogenesis substrates from the knockout phenotype unidentified","Much pathway-level evidence in the corpus derives from the CK2α paralog, not CK2α'"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[4,5,18,11]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[11,2,8]},{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[11,25]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[5,3]},{"term_id":"GO:0005840","term_label":"ribosome","supporting_discovery_ids":[18]}],"pathway":[{"term_id":"R-HSA-9909396","term_label":"Circadian clock","supporting_discovery_ids":[0,27]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[5]},{"term_id":"R-HSA-1474165","term_label":"Reproduction","supporting_discovery_ids":[3]}],"complexes":["CK2 holoenzyme (CK2α'/CK2β)"],"partners":["CSNK2B","BRMS1","CASP3","KIF5C","SOD1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P19784","full_name":"Casein kinase II subunit alpha'","aliases":[],"length_aa":350,"mass_kda":41.2,"function":"Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine (PubMed:11239457, PubMed:11704824, PubMed:16193064, PubMed:30898438). Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection (PubMed:11704824, PubMed:16193064, PubMed:30898438). May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response (PubMed:12631575, PubMed:19387551, PubMed:19387552). During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage (PubMed:12631575, PubMed:19387551, PubMed:19387552). Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation (PubMed:11239457). Phosphorylates a number of DNA repair proteins in response to DNA damage, such as MDC1, RAD9A, RAD51 and HTATSF1, promoting their recruitment to DNA damage sites (PubMed:20545769, PubMed:21482717, PubMed:22325354, PubMed:26811421, PubMed:30898438, PubMed:35597237). Can also negatively regulate apoptosis (PubMed:19387551, PubMed:19387552). Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3 (PubMed:12631575, PubMed:19387551, PubMed:19387552). Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8 (PubMed:12631575, PubMed:19387551, PubMed:19387552). Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV (PubMed:12631575, PubMed:19387551, PubMed:19387552). Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX, JUN, FOS, MYC and MYB (PubMed:12631575, PubMed:19387551, PubMed:19387552). Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function (PubMed:19387550). Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1 (PubMed:19387549). Acts as an ectokinase that phosphorylates several extracellular proteins (PubMed:12631575, PubMed:19387551, PubMed:19387552). During viral infection, phosphorylates various proteins involved in the viral life cycles of EBV, HSV, HBV, HCV, HIV, CMV and HPV (PubMed:12631575, PubMed:19387551, PubMed:19387552). May phosphorylate histone H2A on 'Ser-1' (PubMed:38334665)","subcellular_location":"Nucleus; Cytoplasm","url":"https://www.uniprot.org/uniprotkb/P19784/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CSNK2A2","classification":"Not Classified","n_dependent_lines":7,"n_total_lines":1208,"dependency_fraction":0.005794701986754967},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000070770","cell_line_id":"CID000854","localizations":[{"compartment":"big_aggregates","grade":3},{"compartment":"cytoplasmic","grade":3},{"compartment":"nuclear_punctae","grade":3},{"compartment":"nucleoplasm","grade":3}],"interactors":[{"gene":"CSNK2B","stoichiometry":10.0},{"gene":"MAPK3","stoichiometry":10.0},{"gene":"NUCKS1","stoichiometry":10.0},{"gene":"RPL27","stoichiometry":4.0},{"gene":"POLR2F","stoichiometry":4.0},{"gene":"NCL","stoichiometry":4.0},{"gene":"COPB2","stoichiometry":4.0},{"gene":"SF3B4","stoichiometry":0.2},{"gene":"TSR1","stoichiometry":0.2},{"gene":"DDB1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID000854","total_profiled":1310},"omim":[{"mim_id":"612506","title":"UBIQUITIN-CONJUGATING ENZYME E2 R2; UBE2R2","url":"https://www.omim.org/entry/612506"},{"mim_id":"608335","title":"PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY O, MEMBER 1; PLEKHO1","url":"https://www.omim.org/entry/608335"},{"mim_id":"605926","title":"PROTEIN INTERACTING WITH C KINASE 1; PICK1","url":"https://www.omim.org/entry/605926"},{"mim_id":"600778","title":"CYCLIN-DEPENDENT KINASE INHIBITOR 1B; CDKN1B","url":"https://www.omim.org/entry/600778"},{"mim_id":"600140","title":"CREB-BINDING PROTEIN; CREBBP","url":"https://www.omim.org/entry/600140"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"testis","ntpm":113.9}],"url":"https://www.proteinatlas.org/search/CSNK2A2"},"hgnc":{"alias_symbol":["CSNK2A1","CK2alpha'"],"prev_symbol":[]},"alphafold":{"accession":"P19784","domains":[{"cath_id":"3.30.200.20","chopping":"23-114","consensus_level":"high","plddt":96.8308,"start":23,"end":114},{"cath_id":"1.10.510.10","chopping":"121-331","consensus_level":"high","plddt":97.6058,"start":121,"end":331}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P19784","model_url":"https://alphafold.ebi.ac.uk/files/AF-P19784-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P19784-F1-predicted_aligned_error_v6.png","plddt_mean":94.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CSNK2A2","jax_strain_url":"https://www.jax.org/strain/search?query=CSNK2A2"},"sequence":{"accession":"P19784","fasta_url":"https://rest.uniprot.org/uniprotkb/P19784.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P19784/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P19784"}},"corpus_meta":[{"pmid":"29540794","id":"PMC_29540794","title":"Pathogenesis of cardiac ischemia reperfusion injury is associated with CK2α-disturbed mitochondrial homeostasis via suppression of FUNDC1-related mitophagy.","date":"2018","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/29540794","citation_count":357,"is_preprint":false},{"pmid":"29744594","id":"PMC_29744594","title":"NR4A1 aggravates the cardiac microvascular ischemia reperfusion injury through suppressing FUNDC1-mediated mitophagy and promoting Mff-required mitochondrial fission by CK2α.","date":"2018","source":"Basic research in cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/29744594","citation_count":277,"is_preprint":false},{"pmid":"33376625","id":"PMC_33376625","title":"ALKBH5 Inhibited Cell Proliferation and Sensitized Bladder Cancer Cells to Cisplatin by m6A-CK2α-Mediated Glycolysis.","date":"2020","source":"Molecular therapy. Nucleic acids","url":"https://pubmed.ncbi.nlm.nih.gov/33376625","citation_count":153,"is_preprint":false},{"pmid":"9662328","id":"PMC_9662328","title":"p53 deficiency and misexpression of protein kinase CK2alpha collaborate in the development of thymic lymphomas in mice.","date":"1998","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/9662328","citation_count":140,"is_preprint":false},{"pmid":"24098452","id":"PMC_24098452","title":"miR-125b acts as a tumor suppressor in breast tumorigenesis via its novel direct targets ENPEP, CK2-α, CCNJ, and MEGF9.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24098452","citation_count":130,"is_preprint":false},{"pmid":"15273306","id":"PMC_15273306","title":"Evolutionary constraints associated with functional specificity of the CMGC protein kinases MAPK, CDK, GSK, SRPK, DYRK, and CK2alpha.","date":"2004","source":"Protein science : a publication of the Protein Society","url":"https://pubmed.ncbi.nlm.nih.gov/15273306","citation_count":129,"is_preprint":false},{"pmid":"10622724","id":"PMC_10622724","title":"Protein kinase CK2: evidence for a protein kinase CK2beta subunit fraction, devoid of the catalytic CK2alpha subunit, in mouse brain and testicles.","date":"1999","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/10622724","citation_count":114,"is_preprint":false},{"pmid":"19330005","id":"PMC_19330005","title":"CK2alpha phosphorylates BMAL1 to regulate the mammalian clock.","date":"2009","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19330005","citation_count":111,"is_preprint":false},{"pmid":"9694889","id":"PMC_9694889","title":"Protein kinase CK2alpha' is induced by serum as a delayed early gene and cooperates with Ha-ras in fibroblast transformation.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9694889","citation_count":109,"is_preprint":false},{"pmid":"34418601","id":"PMC_34418601","title":"Paeonol promotes Opa1-mediated mitochondrial fusion via activating the CK2α-Stat3 pathway in diabetic cardiomyopathy.","date":"2021","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/34418601","citation_count":98,"is_preprint":false},{"pmid":"21702981","id":"PMC_21702981","title":"Protein kinase CK2α is overexpressed in colorectal cancer and modulates cell proliferation and invasion via regulating EMT-related genes.","date":"2011","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/21702981","citation_count":96,"is_preprint":false},{"pmid":"27746184","id":"PMC_27746184","title":"CK2α/CSNK2A1 Phosphorylates SIRT6 and Is Involved in the Progression of Breast Carcinoma and Predicts Shorter Survival of Diagnosed Patients.","date":"2016","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/27746184","citation_count":75,"is_preprint":false},{"pmid":"22768056","id":"PMC_22768056","title":"Inhibition of CK2α down-regulates Hedgehog/Gli signaling leading to a reduction of a stem-like side population in human lung cancer cells.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22768056","citation_count":71,"is_preprint":false},{"pmid":"12950107","id":"PMC_12950107","title":"Spermatogenesis of mice lacking CK2alpha': failure of germ cell survival and characteristic modifications of the spermatid nucleus.","date":"2003","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/12950107","citation_count":69,"is_preprint":false},{"pmid":"10862016","id":"PMC_10862016","title":"Antisense oligonucleotides against protein kinase CK2-alpha inhibit growth of squamous cell carcinoma of the head and neck in vitro.","date":"2000","source":"Head & neck","url":"https://pubmed.ncbi.nlm.nih.gov/10862016","citation_count":66,"is_preprint":false},{"pmid":"28451126","id":"PMC_28451126","title":"Specific inhibition of CK2α from an anchor outside the active site.","date":"2016","source":"Chemical science","url":"https://pubmed.ncbi.nlm.nih.gov/28451126","citation_count":57,"is_preprint":false},{"pmid":"17524418","id":"PMC_17524418","title":"Evolved to be active: sulfate ions define substrate recognition sites of CK2alpha and emphasise its exceptional role within the CMGC family of eukaryotic protein kinases.","date":"2007","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17524418","citation_count":55,"is_preprint":false},{"pmid":"21194925","id":"PMC_21194925","title":"Protein kinase CK2α subunit over-expression correlates with metastatic risk in breast carcinomas: quantitative immunohistochemistry in tissue microarrays.","date":"2010","source":"European journal of cancer (Oxford, England : 1990)","url":"https://pubmed.ncbi.nlm.nih.gov/21194925","citation_count":54,"is_preprint":false},{"pmid":"18824508","id":"PMC_18824508","title":"The interaction of CK2alpha and CK2beta, the subunits of protein kinase CK2, requires CK2beta in a preformed conformation and is enthalpically driven.","date":"2008","source":"Protein science : a publication of the Protein Society","url":"https://pubmed.ncbi.nlm.nih.gov/18824508","citation_count":51,"is_preprint":false},{"pmid":"29510389","id":"PMC_29510389","title":"Inhibition of MiRNA-125b Decreases Cerebral Ischemia/Reperfusion Injury by Targeting CK2α/NADPH Oxidase Signaling.","date":"2018","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/29510389","citation_count":48,"is_preprint":false},{"pmid":"19188443","id":"PMC_19188443","title":"Evidence for regulation of mitotic progression through temporal phosphorylation and dephosphorylation of CK2alpha.","date":"2009","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19188443","citation_count":48,"is_preprint":false},{"pmid":"10849443","id":"PMC_10849443","title":"Transcription factors ets1, NF-kappa B, and Sp1 are major determinants of the promoter activity of the human protein kinase CK2alpha gene.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10849443","citation_count":47,"is_preprint":false},{"pmid":"28209983","id":"PMC_28209983","title":"Generation and quantitative proteomics analysis of CK2α/α'(-/-) cells.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28209983","citation_count":46,"is_preprint":false},{"pmid":"23651443","id":"PMC_23651443","title":"Inhibition of CK2α down-regulates Notch1 signalling in lung cancer cells.","date":"2013","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23651443","citation_count":45,"is_preprint":false},{"pmid":"18208335","id":"PMC_18208335","title":"Dominant-negative CK2alpha induces potent effects on circadian rhythmicity.","date":"2007","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18208335","citation_count":43,"is_preprint":false},{"pmid":"21241709","id":"PMC_21241709","title":"Structure of the human protein kinase CK2 catalytic subunit CK2α' and interaction thermodynamics with the regulatory subunit CK2β.","date":"2011","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/21241709","citation_count":43,"is_preprint":false},{"pmid":"9671309","id":"PMC_9671309","title":"Protein kinase CK2alpha is a target for the Abl and Bcr-Abl tyrosine kinases.","date":"1998","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/9671309","citation_count":42,"is_preprint":false},{"pmid":"24254769","id":"PMC_24254769","title":"Attenuation of β-amyloid-induced tauopathy via activation of CK2α/SIRT1: targeting for cilostazol.","date":"2013","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/24254769","citation_count":40,"is_preprint":false},{"pmid":"16335523","id":"PMC_16335523","title":"Primary and secondary interactions between CK2alpha and CK2beta lead to ring-like structures in the crystals of the CK2 holoenzyme.","date":"2005","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16335523","citation_count":38,"is_preprint":false},{"pmid":"28237649","id":"PMC_28237649","title":"Protein kinase CK2α catalytic subunit ameliorates diabetic renal inflammatory fibrosis via NF-κB signaling pathway.","date":"2017","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/28237649","citation_count":35,"is_preprint":false},{"pmid":"23599180","id":"PMC_23599180","title":"Characterizing the convergence of protein kinase CK2 and caspase-3 reveals isoform-specific phosphorylation of caspase-3 by CK2α': implications for pathological roles of CK2 in promoting cancer cell survival.","date":"2013","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/23599180","citation_count":35,"is_preprint":false},{"pmid":"20734498","id":"PMC_20734498","title":"Relative role of halogen bonds and hydrophobic interactions in inhibition of human protein kinase CK2α by tetrabromobenzotriazole and some C5-substituted analogues.","date":"2010","source":"The journal of physical chemistry. B","url":"https://pubmed.ncbi.nlm.nih.gov/20734498","citation_count":34,"is_preprint":false},{"pmid":"21761204","id":"PMC_21761204","title":"Systemic administration of antisense oligonucleotides simultaneously targeting CK2α and α' subunits reduces orthotopic xenograft prostate tumors in mice.","date":"2011","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21761204","citation_count":34,"is_preprint":false},{"pmid":"29732088","id":"PMC_29732088","title":"Second-generation CK2α inhibitors targeting the αD pocket.","date":"2018","source":"Chemical science","url":"https://pubmed.ncbi.nlm.nih.gov/29732088","citation_count":34,"is_preprint":false},{"pmid":"21761202","id":"PMC_21761202","title":"Predominance of CK2α over CK2α' in the mammalian brain.","date":"2011","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21761202","citation_count":32,"is_preprint":false},{"pmid":"22184066","id":"PMC_22184066","title":"Phosphorylation of the transcription factor YY1 by CK2α prevents cleavage by caspase 7 during apoptosis.","date":"2011","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/22184066","citation_count":32,"is_preprint":false},{"pmid":"24616922","id":"PMC_24616922","title":"Oncogenic potential of CK2α and its regulatory role in EGF-induced HDAC2 expression in human liver cancer.","date":"2014","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/24616922","citation_count":31,"is_preprint":false},{"pmid":"15284227","id":"PMC_15284227","title":"MAP kinase phosphatase 3 (MKP3) interacts with and is phosphorylated by protein kinase CK2alpha.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15284227","citation_count":31,"is_preprint":false},{"pmid":"21761203","id":"PMC_21761203","title":"CK2α is essential for embryonic morphogenesis.","date":"2011","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21761203","citation_count":31,"is_preprint":false},{"pmid":"27226552","id":"PMC_27226552","title":"Protein Kinase CK2α Maintains Extracellular Signal-regulated Kinase (ERK) Activity in a CK2α Kinase-independent Manner to Promote Resistance to Inhibitors of RAF and MEK but Not ERK in BRAF Mutant Melanoma.","date":"2016","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27226552","citation_count":30,"is_preprint":false},{"pmid":"26980766","id":"PMC_26980766","title":"CK2α' Drives Lung Cancer Metastasis by Targeting BRMS1 Nuclear Export and Degradation.","date":"2016","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/26980766","citation_count":30,"is_preprint":false},{"pmid":"31091289","id":"PMC_31091289","title":"Activity of CK2α protein kinase is required for efficient replication of some HPV types.","date":"2019","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/31091289","citation_count":29,"is_preprint":false},{"pmid":"31183056","id":"PMC_31183056","title":"Efficient development of stable and highly functionalised peptides targeting the CK2α/CK2β protein-protein interaction.","date":"2019","source":"Chemical science","url":"https://pubmed.ncbi.nlm.nih.gov/31183056","citation_count":29,"is_preprint":false},{"pmid":"29625966","id":"PMC_29625966","title":"Identification of ST3AGL4, MFHAS1, CSNK2A2 and CD226 as loci associated with systemic lupus erythematosus (SLE) and evaluation of SLE genetics in drug repositioning.","date":"2018","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/29625966","citation_count":28,"is_preprint":false},{"pmid":"12901717","id":"PMC_12901717","title":"Eukaryotic translation-initiation factor eIF2beta binds to protein kinase CK2: effects on CK2alpha activity.","date":"2003","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/12901717","citation_count":28,"is_preprint":false},{"pmid":"20625391","id":"PMC_20625391","title":"Functional polymorphism of the CK2alpha intronless gene plays oncogenic roles in lung cancer.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20625391","citation_count":28,"is_preprint":false},{"pmid":"21739155","id":"PMC_21739155","title":"Structural and functional determinants of protein kinase CK2α: facts and open questions.","date":"2011","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21739155","citation_count":27,"is_preprint":false},{"pmid":"24958341","id":"PMC_24958341","title":"Stable knockdown of protein kinase CK2-alpha (CK2α) inhibits migration and invasion and induces inactivation of hedgehog signaling pathway in hepatocellular carcinoma Hep G2 cells.","date":"2014","source":"Acta histochemica","url":"https://pubmed.ncbi.nlm.nih.gov/24958341","citation_count":27,"is_preprint":false},{"pmid":"10094410","id":"PMC_10094410","title":"CK2alpha-protein phosphatase 2A molecular complex: possible interaction with the MAP kinase pathway.","date":"1999","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10094410","citation_count":26,"is_preprint":false},{"pmid":"22115617","id":"PMC_22115617","title":"CK2α and CK2α' subunits differ in their sensitivity to 4,5,6,7-tetrabromo- and 4,5,6,7-tetraiodo-1H-benzimidazole derivatives.","date":"2011","source":"European journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22115617","citation_count":25,"is_preprint":false},{"pmid":"26974875","id":"PMC_26974875","title":"Underlying mechanisms of cyclic peptide inhibitors interrupting the interaction of CK2α/CK2β: comparative molecular dynamics simulation studies.","date":"2016","source":"Physical chemistry chemical physics : PCCP","url":"https://pubmed.ncbi.nlm.nih.gov/26974875","citation_count":25,"is_preprint":false},{"pmid":"25422081","id":"PMC_25422081","title":"CK2α, over-expressed in human malignant pleural mesothelioma, regulates the Hedgehog signaling pathway in mesothelioma cells.","date":"2014","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/25422081","citation_count":24,"is_preprint":false},{"pmid":"19363471","id":"PMC_19363471","title":"Combined inhibition of PAK7, MAP3K7 and CK2alpha kinases inhibits the growth of MiaPaCa2 pancreatic cancer cell xenografts.","date":"2009","source":"Cancer gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/19363471","citation_count":24,"is_preprint":false},{"pmid":"15276436","id":"PMC_15276436","title":"Identification of barley CK2alpha targets by using the protein microarray technology.","date":"2004","source":"Phytochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15276436","citation_count":24,"is_preprint":false},{"pmid":"16442308","id":"PMC_16442308","title":"Purification and characterization of the CK2alpha'-based holoenzyme, an isozyme of CK2alpha: a comparative analysis.","date":"2005","source":"Protein expression and purification","url":"https://pubmed.ncbi.nlm.nih.gov/16442308","citation_count":23,"is_preprint":false},{"pmid":"21693590","id":"PMC_21693590","title":"Localization of phosphorylated CK2alpha to the mitotic spindle requires the peptidyl-prolyl isomerase Pin1.","date":"2011","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/21693590","citation_count":23,"is_preprint":false},{"pmid":"27251789","id":"PMC_27251789","title":"Phosphoproteomic Analyses of NRAS(G12) and NRAS(Q61) Mutant Melanocytes Reveal Increased CK2α Kinase Levels in NRAS(Q61) Mutant Cells.","date":"2016","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/27251789","citation_count":22,"is_preprint":false},{"pmid":"16335532","id":"PMC_16335532","title":"The catalytic subunit alpha' gene of human protein kinase CK2 (CSNK2A2): genomic organization, promoter identification and determination of Ets1 as a key regulator.","date":"2005","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16335532","citation_count":21,"is_preprint":false},{"pmid":"21142136","id":"PMC_21142136","title":"Interaction between CK2α and CK2β, the subunits of protein kinase CK2: thermodynamic contributions of key residues on the CK2α surface.","date":"2010","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21142136","citation_count":21,"is_preprint":false},{"pmid":"28043654","id":"PMC_28043654","title":"Selected flavonoid compounds as promising inhibitors of protein kinase CK2α and CK2α', the catalytic subunits of CK2.","date":"2016","source":"Phytochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28043654","citation_count":21,"is_preprint":false},{"pmid":"36271116","id":"PMC_36271116","title":"In silico investigations identified Butyl Xanalterate to competently target CK2α (CSNK2A1) for therapy of chronic lymphocytic leukemia.","date":"2022","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/36271116","citation_count":21,"is_preprint":false},{"pmid":"15034935","id":"PMC_15034935","title":"Atomic structure of a CK2alpha human kinase by microfocus diffraction of extra-small microcrystals grown with nanobiofilm template.","date":"2004","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15034935","citation_count":21,"is_preprint":false},{"pmid":"28270146","id":"PMC_28270146","title":"BMI1, a new target of CK2α.","date":"2017","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/28270146","citation_count":20,"is_preprint":false},{"pmid":"34323071","id":"PMC_34323071","title":"Molecular Plasticity of Crystalline CK2α' Leads to KN2, a Bivalent Inhibitor of Protein Kinase CK2 with Extraordinary Selectivity.","date":"2021","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/34323071","citation_count":20,"is_preprint":false},{"pmid":"21739153","id":"PMC_21739153","title":"Enzymatic activity with an incomplete catalytic spine: insights from a comparative structural analysis of human CK2α and its paralogous isoform CK2α'.","date":"2011","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21739153","citation_count":20,"is_preprint":false},{"pmid":"31559376","id":"PMC_31559376","title":"Diacritic Binding of an Indenoindole Inhibitor by CK2α Paralogs Explored by a Reliable Path to Atomic Resolution CK2α' Structures.","date":"2019","source":"ACS omega","url":"https://pubmed.ncbi.nlm.nih.gov/31559376","citation_count":20,"is_preprint":false},{"pmid":"24121351","id":"PMC_24121351","title":"Crystal structure of human CK2α at 1.06 Å resolution.","date":"2013","source":"Journal of synchrotron radiation","url":"https://pubmed.ncbi.nlm.nih.gov/24121351","citation_count":20,"is_preprint":false},{"pmid":"33944995","id":"PMC_33944995","title":"Okur-Chung neurodevelopmental syndrome-linked CK2α variants have reduced kinase activity.","date":"2021","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33944995","citation_count":19,"is_preprint":false},{"pmid":"29555935","id":"PMC_29555935","title":"PIWIL2 suppresses Siah2-mediated degradation of HDAC3 and facilitates CK2α-mediated HDAC3 phosphorylation.","date":"2018","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/29555935","citation_count":18,"is_preprint":false},{"pmid":"27435858","id":"PMC_27435858","title":"Examination of CK2α and NF-κB p65 expression in human benign prostatic hyperplasia and prostate cancer tissues.","date":"2016","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27435858","citation_count":18,"is_preprint":false},{"pmid":"25891901","id":"PMC_25891901","title":"Thermodynamics parameters for binding of halogenated benzotriazole inhibitors of human protein kinase CK2α.","date":"2015","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/25891901","citation_count":18,"is_preprint":false},{"pmid":"33119282","id":"PMC_33119282","title":"Proposed Allosteric Inhibitors Bind to the ATP Site of CK2α.","date":"2020","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33119282","citation_count":18,"is_preprint":false},{"pmid":"25233003","id":"PMC_25233003","title":"Development of a high-throughput screening-compatible assay to identify inhibitors of the CK2α/CK2β interaction.","date":"2014","source":"Analytical biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25233003","citation_count":18,"is_preprint":false},{"pmid":"25961323","id":"PMC_25961323","title":"A Note of Caution on the Role of Halogen Bonds for Protein Kinase/Inhibitor Recognition Suggested by High- And Low-Salt CK2α Complex Structures.","date":"2015","source":"ACS chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/25961323","citation_count":18,"is_preprint":false},{"pmid":"29179493","id":"PMC_29179493","title":"Sphingosine kinase 1 mediates diabetic renal fibrosis via NF-κB signaling pathway: involvement of CK2α.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29179493","citation_count":17,"is_preprint":false},{"pmid":"12849977","id":"PMC_12849977","title":"The protein kinase 60S is a free catalytic CK2alpha' subunit and forms an inactive complex with superoxide dismutase SOD1.","date":"2003","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12849977","citation_count":17,"is_preprint":false},{"pmid":"23155426","id":"PMC_23155426","title":"Isomeric mono-, di-, and tri-bromobenzo-1H-triazoles as inhibitors of human protein kinase CK2α.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23155426","citation_count":17,"is_preprint":false},{"pmid":"12582614","id":"PMC_12582614","title":"Molecular cloning of the wheat CK2alpha gene and detection of its linkage with Vrn-A1 on chromosome 5A.","date":"2002","source":"TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik","url":"https://pubmed.ncbi.nlm.nih.gov/12582614","citation_count":17,"is_preprint":false},{"pmid":"34359939","id":"PMC_34359939","title":"CK2α/CSNK2A1 Induces Resistance to Doxorubicin through SIRT6-Mediated Activation of the DNA Damage Repair Pathway.","date":"2021","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/34359939","citation_count":16,"is_preprint":false},{"pmid":"19011756","id":"PMC_19011756","title":"KIF5C: a new binding partner for protein kinase CK2 with a preference for the CK2alpha' subunit.","date":"2009","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/19011756","citation_count":16,"is_preprint":false},{"pmid":"16606343","id":"PMC_16606343","title":"BID, an interaction partner of protein kinase CK2alpha.","date":"2006","source":"Biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16606343","citation_count":16,"is_preprint":false},{"pmid":"30786177","id":"PMC_30786177","title":"Design of CK2β-Mimicking Peptides as Tools To Study the CK2α/CK2β Interaction in Cancer Cells.","date":"2019","source":"ChemMedChem","url":"https://pubmed.ncbi.nlm.nih.gov/30786177","citation_count":16,"is_preprint":false},{"pmid":"11168379","id":"PMC_11168379","title":"The C-terminal domain of human grp94 protects the catalytic subunit of protein kinase CK2 (CK2alpha) against thermal aggregation. Role of disulfide bonds.","date":"2001","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11168379","citation_count":16,"is_preprint":false},{"pmid":"11827174","id":"PMC_11827174","title":"Transcriptional coordination of the genes encoding catalytic (CK2alpha) and regulatory (CK2beta) subunits of human protein kinase CK2.","date":"2001","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11827174","citation_count":15,"is_preprint":false},{"pmid":"26786382","id":"PMC_26786382","title":"Toward selective CK2alpha and CK2alpha' inhibitors: Development of a novel whole-cell kinase assay by Autodisplay of catalytic CK2alpha'.","date":"2016","source":"Journal of pharmaceutical and biomedical analysis","url":"https://pubmed.ncbi.nlm.nih.gov/26786382","citation_count":15,"is_preprint":false},{"pmid":"14962846","id":"PMC_14962846","title":"Proapoptotic function of protein kinase CK2alpha\" is mediated by a JNK signaling cascade.","date":"2004","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/14962846","citation_count":15,"is_preprint":false},{"pmid":"10094393","id":"PMC_10094393","title":"CK2alpha loci in the human genome: structure and transcriptional activity.","date":"1999","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10094393","citation_count":15,"is_preprint":false},{"pmid":"23840637","id":"PMC_23840637","title":"An in vitro ES cell-based clock recapitulation assay model identifies CK2α as an endogenous clock regulator.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23840637","citation_count":15,"is_preprint":false},{"pmid":"22422579","id":"PMC_22422579","title":"Protection by cilostazol against amyloid-β(1-40)-induced suppression of viability and neurite elongation through activation of CK2α in HT22 mouse hippocampal cells.","date":"2012","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/22422579","citation_count":15,"is_preprint":false},{"pmid":"37944834","id":"PMC_37944834","title":"Ginsenoside Rh1, a novel casein kinase II subunit alpha (CK2α) inhibitor, retards metastasis via disrupting HHEX/CCL20 signaling cascade involved in tumor cell extravasation across endothelial barrier.","date":"2023","source":"Pharmacological research","url":"https://pubmed.ncbi.nlm.nih.gov/37944834","citation_count":14,"is_preprint":false},{"pmid":"32800562","id":"PMC_32800562","title":"A N-terminally deleted form of the CK2α' catalytic subunit is sufficient to support cell viability.","date":"2020","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/32800562","citation_count":14,"is_preprint":false},{"pmid":"12417343","id":"PMC_12417343","title":"Role of the carboxyl terminus on the catalytic activity of protein kinase CK2alpha subunit.","date":"2002","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/12417343","citation_count":13,"is_preprint":false},{"pmid":"25036794","id":"PMC_25036794","title":"Synthesis of novel chiral TBBt derivatives with hydroxyl moiety. Studies on inhibition of human protein kinase CK2α and cytotoxicity properties.","date":"2014","source":"European journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25036794","citation_count":13,"is_preprint":false},{"pmid":"29236079","id":"PMC_29236079","title":"Unexpected Binding Mode of a Potent Indeno[1,2-b]indole-Type Inhibitor of Protein Kinase CK2 Revealed by Complex Structures with the Catalytic Subunit CK2α and Its Paralog CK2α'.","date":"2017","source":"Pharmaceuticals (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/29236079","citation_count":12,"is_preprint":false},{"pmid":"24831064","id":"PMC_24831064","title":"RNA interference (RNAi) mediated stable knockdown of protein casein kinase 2-alpha (CK2α) inhibits migration and invasion and enhances cisplatin-induced apoptosis in HEp-2 laryngeal carcinoma cells.","date":"2014","source":"Acta histochemica","url":"https://pubmed.ncbi.nlm.nih.gov/24831064","citation_count":12,"is_preprint":false},{"pmid":"31713447","id":"PMC_31713447","title":"Co-targeting CK2α and YBX1 suppresses tumor progression by coordinated inhibition of the PI3K/AKT signaling pathway.","date":"2019","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/31713447","citation_count":11,"is_preprint":false},{"pmid":"35445078","id":"PMC_35445078","title":"Structural and Enzymological Evidence for an Altered Substrate Specificity in Okur-Chung Neurodevelopmental Syndrome Mutant CK2αLys198Arg.","date":"2022","source":"Frontiers in molecular biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/35445078","citation_count":11,"is_preprint":false},{"pmid":"38649679","id":"PMC_38649679","title":"CK2α-mediated phosphorylation of GRP94 facilitates the metastatic cascade in triple-negative breast cancer.","date":"2024","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/38649679","citation_count":11,"is_preprint":false},{"pmid":"38132153","id":"PMC_38132153","title":"Protein Kinase CK2α', More than a Backup of CK2α.","date":"2023","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/38132153","citation_count":10,"is_preprint":false},{"pmid":"12831533","id":"PMC_12831533","title":"Epitope analysis of the MAb 1AD9 antibody detection site in human protein kinase CK2alpha-subunit.","date":"2003","source":"Hybridoma and hybridomics","url":"https://pubmed.ncbi.nlm.nih.gov/12831533","citation_count":10,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50239,"output_tokens":8768,"usd":0.141119,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":19134,"output_tokens":3470,"usd":0.09121,"stage2_stop_reason":"end_turn"},"total_usd":0.232329,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2009,\n      \"finding\": \"CK2α phosphorylates the circadian regulator BMAL1 at Ser90; gene silencing of CK2α or mutation of Ser90 impairs nuclear BMAL1 accumulation and disrupts circadian clock function, and phosphorylation at Ser90 follows a rhythmic pattern.\",\n      \"method\": \"Gene silencing (siRNA), site-directed mutagenesis, phosphorylation assays, nuclear localization assays\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal genetic and biochemical evidence (silencing + mutagenesis + localization assay), published in high-quality journal with multiple orthogonal methods\",\n      \"pmids\": [\"19330005\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Dominant-negative CK2α (CK2αTik) in Drosophila clock neurons reduces PER phosphorylation, delays nuclear entry of PER, dampens PER cycling, and prolongs circadian period (~33 h), establishing CK2α as a key regulator of PER negative feedback timing.\",\n      \"method\": \"Transgenic dominant-negative expression in circadian neurons, behavioral rhythmicity assay, immunostaining for PER phosphorylation and nuclear localization\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal in vivo methods (behavioral, molecular, immunostaining) with genetic controls in Drosophila model organism\",\n      \"pmids\": [\"18208335\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Crystal structure of human CK2α' determined at 2 Å resolution. CK2α' has ~12-fold lower affinity for CK2β than CK2α (Kd ~150 nM vs ~13 nM), driven less by enthalpy. The β4/β5 loop in CK2α' adopts an open conformation stabilized by an N-terminal β-strand extension and a tryptophan filling a conserved hydrophobic cavity, features absent in CK2α.\",\n      \"method\": \"X-ray crystallography, isothermal titration calorimetry (ITC), Michaelis-Menten kinetics\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure plus ITC thermodynamics, multiple orthogonal methods in one rigorous study\",\n      \"pmids\": [\"21241709\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Disruption of Csnk2a2 (CK2α') in male mice causes infertility and oligozoospermia with spermatid nuclear abnormalities, nuclear envelope protrusions, loss of nuclear pores, and extensive germ cell death at all spermatogenic stages, indicating CK2α' is required for phosphorylation of nuclear proteins in male germ cells.\",\n      \"method\": \"Gene knockout in mice, histology, electron microscopy, fluorescent DNA staining\",\n      \"journal\": \"Molecular reproduction and development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO with specific ultrastructural and cellular phenotype, multiple methods\",\n      \"pmids\": [\"12950107\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CK2α' (CSNK2A2) exhibits a striking isoform-specific preference for phosphorylating caspase-3 in cells compared to CK2α, and CK2β abolishes caspase-3 phosphorylation; caspase-3 is the first substrate selectively phosphorylated by CK2α' in cells.\",\n      \"method\": \"Modulation of individual CK2 subunit expression (siRNA knockdown and overexpression), cell-based phosphorylation assays\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-based approach with multiple subunit manipulations, single lab, two orthogonal methods\",\n      \"pmids\": [\"23599180\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"CK2α' phosphorylates nuclear BRMS1 at Ser30 in response to TNF, causing 14-3-3ε-mediated nuclear export and ubiquitin-proteasome degradation of BRMS1, thereby promoting lung cancer metastasis; S30 mutation or CK2 inhibitor CX4945 abrogates this effect and reduces metastasis ~60-fold in vivo.\",\n      \"method\": \"In vitro kinase assay, site-directed mutagenesis (S30A), orthotopic mouse metastasis model, co-immunoprecipitation, siRNA, small-molecule inhibitor\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro kinase assay + mutagenesis + in vivo model + multiple biochemical methods converging on the same mechanism\",\n      \"pmids\": [\"26980766\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CK2α is phosphorylated at four sites during mitosis (maximally in prophase/metaphase) and dephosphorylated during anaphase/telophase; phosphomimetic CK2α (4D/4E) causes centrosome amplification, chromosomal segregation defects, and mitotic catastrophe, while non-phosphorylatable CK2α (4A) impairs the spindle assembly checkpoint response.\",\n      \"method\": \"Phosphospecific antibodies, stable expression of phosphomimetic and non-phosphorylatable mutants, immunofluorescence, nocodazole treatment/release\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — phosphospecific antibodies, multiple phosphomutant cell lines, multiple phenotypic readouts in one rigorous study\",\n      \"pmids\": [\"19188443\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Phosphorylated CK2α localizes to the mitotic spindle in a phosphorylation-dependent manner requiring the unique C-terminus of CK2α; this localization requires binding to the peptidyl-prolyl isomerase Pin1, which is facilitated by CK2α phosphorylation.\",\n      \"method\": \"Phosphospecific antibodies, immunofluorescence, co-immunoprecipitation, deletion mutants\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — phosphospecific antibody localization + co-IP + deletion analysis, multiple orthogonal methods linking phosphorylation to spindle localization via Pin1\",\n      \"pmids\": [\"21693590\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"CK2α' mRNA is induced by serum as a delayed early gene in quiescent fibroblasts (peaks at 4 h); ectopic CK2α' cooperates with Ha-ras in foci formation and fibroblast transformation, correlating with increased calmodulin phosphorylation—a substrate specific to free CK2 catalytic subunits rather than holoenzyme.\",\n      \"method\": \"Northern blot, kinase activity assay toward CK2 peptide substrate and calmodulin, foci formation assay in primary rat embryo fibroblasts\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional transformation assay + kinase substrate assay + expression kinetics, multiple orthogonal methods in one study\",\n      \"pmids\": [\"9694889\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"CK2α associates physically with c-Abl and with the Bcr-Abl fusion protein; Bcr-Abl phosphorylates CK2α on tyrosine, inhibiting its kinase activity, and this inhibition is reversed by tyrosine phosphatase treatment.\",\n      \"method\": \"Anti-phosphotyrosine immunoblotting, immunoprecipitation, in vitro kinase assay, tyrosine phosphatase treatment\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP + in vitro phosphorylation + enzymatic reversal, single lab, multiple methods\",\n      \"pmids\": [\"9671309\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"CK2α and CK2β interact with a dissociation constant of 12.6 nM, driven predominantly by enthalpic rather than entropic contributions; CK2β requires a preformed conformation for interaction, while CK2α undergoes significant backbone structural adaptations upon assembly.\",\n      \"method\": \"Isothermal titration calorimetry (ITC), differential scanning calorimetry (DSC), X-ray crystallography of CK2β\",\n      \"journal\": \"Protein science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure + ITC + DSC, multiple orthogonal biophysical methods\",\n      \"pmids\": [\"18824508\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Crystal structure of fully active C-terminal deletion mutant of human CK2α at 1.6 Å with two bound sulfate ions; sulfate anions occupy the activation segment and the +1 loop binding pockets, providing structural basis for the acidic consensus substrate recognition sequence S/T-D/E-X-D/E; CK2α lacks phosphorylatable residues at the activation segment, making it constitutively active.\",\n      \"method\": \"X-ray crystallography (1.6 Å), structural comparison with CMGC kinases\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — high-resolution crystal structure with mechanistic interpretation validated by structural comparison\",\n      \"pmids\": [\"17524418\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"CK2α interacts with MKP3 (MAP kinase phosphatase 3) forming a protein complex that can include ERK2; CK2α selectively phosphorylates MKP3, slightly increasing MKP3 phosphatase activity in vitro but reducing ERK2 dephosphorylation in transfected cells.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, in vitro phosphatase assay, transfection\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast 2-hybrid confirmed by co-IP + in vitro assay + cell-based assay, single lab\",\n      \"pmids\": [\"15284227\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"eIF2β directly binds both CK2α (high affinity) and CK2β (low affinity) as measured by surface plasmon resonance; free CK2α cannot phosphorylate eIF2β but reconstituted CK2 holoenzyme phosphorylates eIF2β (~1.2 mol phosphate/mol); eIF2β inhibits CK2α activity on calmodulin and β-casein but has minimal effect on holoenzyme activity.\",\n      \"method\": \"Surface plasmon resonance, co-immunoprecipitation, in vitro kinase assay with reconstituted holoenzyme\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — SPR binding kinetics + co-IP + in vitro reconstitution assay, multiple orthogonal methods\",\n      \"pmids\": [\"12901717\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"BID is a substrate and binding partner of CK2α; CK2α (but not holoenzyme unless stimulated by polylysine) phosphorylates BID at Thr58 and Ser76; phosphorylation of BID by CK2α prior to caspase-8 cleavage reduces formation of truncated BID (tC-BID); BID co-immunoprecipitates preferentially with CK2α subunit.\",\n      \"method\": \"In vitro kinase assay, co-immunoprecipitation, mass spectrometry, enzyme kinetics\",\n      \"journal\": \"Biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro kinase assay + mass spectrometry site identification + co-IP, single lab\",\n      \"pmids\": [\"16606343\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"KIF5C (a kinesin motor neuron protein) is a direct binding partner of CK2α' with a preference over CK2α; interaction confirmed by co-sedimentation on sucrose gradient, co-immunoprecipitation, pull-down, and surface plasmon resonance; co-localization observed in neuroblastoma cells and primary neurons.\",\n      \"method\": \"Yeast two-hybrid, co-sedimentation, co-immunoprecipitation, pull-down, surface plasmon resonance, co-localization by immunofluorescence\",\n      \"journal\": \"Cellular and molecular life sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal binding assays (SPR, co-IP, co-sedimentation, pull-down) all confirming direct interaction with isoform preference\",\n      \"pmids\": [\"19011756\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"CK2α (CSNK2A1) phosphorylates SIRT6 and physically associates with it; phosphorylation of SIRT6 at Ser338 by CK2α promotes cancer cell proliferation and invasiveness, and mutation at Ser338 inhibits proliferation and decreases MMP9, β-catenin, cyclin D1, and NF-κB expression.\",\n      \"method\": \"Co-immunoprecipitation, GST pull-down assay, in vitro kinase assay, dominant-negative CK2α transfection, SIRT6 Ser338Ala mutant\",\n      \"journal\": \"The American journal of pathology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro kinase assay + co-IP + GST pull-down + mutagenesis, multiple orthogonal methods\",\n      \"pmids\": [\"27746184\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"CK2α phosphorylates the transcription factor YY1 at Ser118 in vitro and in vivo; CK2α inhibition or knockdown reduces Ser118 phosphorylation and enhances YY1 cleavage by caspase 7 during apoptosis; Ser118Ala mutation also increases YY1 cleavage, linking CK2α phosphorylation to protection of YY1 from caspase-mediated cleavage.\",\n      \"method\": \"In vitro kinase assay, siRNA knockdown, CK2α overexpression, site-directed mutagenesis (S118A), apoptosis assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro kinase assay + mutagenesis + siRNA + overexpression with consistent phenotypic readout across multiple methods\",\n      \"pmids\": [\"22184066\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The PK60S kinase from S. cerevisiae 60S ribosomes, which phosphorylates ribosomal P-proteins, was identified as the CK2α' catalytic subunit by peptide mass fingerprinting; CK2α' activity is inhibited by SOD1 (superoxide dismutase), forming an inactive complex.\",\n      \"method\": \"Protein purification, peptide mass fingerprinting (PMF), kinase activity assay, inhibition by SOD1\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — PMF identification + functional kinase assay + inhibition assay, single lab\",\n      \"pmids\": [\"12849977\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"CK2α forms a molecular complex with protein phosphatase 2A (PP2A) core dimer; expression of activated Raf disrupts this CK2α-PP2A association; CK2α overexpression inhibits mitogen-induced MAP kinase activation in a dose-dependent manner.\",\n      \"method\": \"Transfection, immune kinase assays, co-immunoprecipitation\",\n      \"journal\": \"Molecular and cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — co-IP + functional kinase assay + epistasis with Raf, single lab\",\n      \"pmids\": [\"10094410\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"CK2α maintains ERK phosphorylation in BRAF-mutant melanoma through two mechanisms: (1) kinase-dependent post-translational downregulation of the ERK phosphatase DUSP6, and (2) kinase-independent scaffolding via binding to KSR1 (a RAF-MEK-ERK scaffold), with both wild-type and kinase-inactive CK2α binding KSR1 equally.\",\n      \"method\": \"CK2α overexpression/knockdown, kinase-inactive mutant expression, co-immunoprecipitation with KSR1, Western blot for ERK phosphorylation and DUSP6, ERK inhibitor comparison\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — kinase-inactive mutant epistasis + co-IP + multiple inhibitor comparisons, disambiguating kinase-dependent vs. -independent functions\",\n      \"pmids\": [\"27226552\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"CK2α phosphorylates BMI1 at Ser110; preventing this phosphorylation significantly decreases BMI1 half-life and stability; phosphorylatable but not non-phosphorylatable BMI1 rescues clonal growth in BMI1-silenced cancer cells.\",\n      \"method\": \"Immunoprecipitation, in vitro and ex vivo kinase assay, mass spectrometry, siRNA, overexpression of phosphorylation mutants, stability assay\",\n      \"journal\": \"Molecular cancer\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro kinase assay + MS site identification + functional rescue with phosphomutant, multiple orthogonal methods\",\n      \"pmids\": [\"28270146\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CK2α is a positive regulator of Hedgehog/Gli signaling in lung cancer cells; CK2α silencing reduces Gli1 expression and transcriptional activity; forced CK2α overexpression increases Gli1 transcriptional activity; CK2α inhibition reduces the cancer stem-like side population with elevated ABCG2.\",\n      \"method\": \"siRNA knockdown, forced overexpression, luciferase reporter assay, RT-PCR, small-molecule CK2α inhibitors\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — siRNA + OE + pharmacological inhibition converging, single lab, no direct biochemical mechanism identified\",\n      \"pmids\": [\"22768056\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CK2α phosphorylates FUNDC1 at Ser13, inactivating FUNDC1-mediated mitophagy; cardiac-specific CK2α knockout preserves mitophagy and protects against IR injury; mice doubly deficient in CK2α and FUNDC1 lose the protective effect, confirming epistasis.\",\n      \"method\": \"Cardiac-specific CK2α knockout mice, double knockout (CK2α + FUNDC1), phosphorylation assays, mitophagy functional assays\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO + double KO epistasis + phosphorylation assay, single lab\",\n      \"pmids\": [\"29540794\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"NR4A1 activates CK2α, which then phosphorylates Mff to promote Drp1-dependent mitochondrial fission and phosphorylates FUNDC1 to inhibit mitophagy, together driving endothelial apoptosis in microvascular IR injury.\",\n      \"method\": \"NR4A1 knockout mice, siRNA, phosphorylation assays, Drp1 translocation assay, mitophagy assay\",\n      \"journal\": \"Basic research in cardiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO + phosphorylation assays + functional readouts, single lab\",\n      \"pmids\": [\"29744594\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"A novel binding site on CK2α adjacent to the ATP site (αD pocket) was identified; a bivalent inhibitor (CAM4066, Kd = 320 nM) anchored in this αD pocket linked to a fragment in the ATP site inhibits CK2α with improved selectivity and shows cellular target engagement.\",\n      \"method\": \"Fragment-based drug discovery, X-ray crystallography, ITC, cell viability assays\",\n      \"journal\": \"Chemical science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure + ITC + cellular engagement, identifying a novel allosteric-adjacent binding pocket\",\n      \"pmids\": [\"28451126\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Dual knockout of both CK2α and CK2α' catalytic subunits (by CRISPR/Cas9) promotes accelerated proteasomal degradation of the CK2β regulatory subunit and causes rearrangement of the proteome with >240 proteins altered >50% in level.\",\n      \"method\": \"CRISPR/Cas9 gene editing, quantitative proteomics, proteasome inhibitor treatment\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — CRISPR KO + quantitative proteomics, mechanistically links CK2 catalytic subunits to CK2β stability\",\n      \"pmids\": [\"28209983\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"In an ES cell-based circadian assay, homozygous CK2α mutant ES cells show ~2.5-hour longer circadian periods after differentiation, providing genetic evidence for an essential role of CK2α in the mammalian circadian clock.\",\n      \"method\": \"Homozygous CK2α mutant ES cells, in vitro differentiation, circadian reporter assay, revertant cell line confirmation\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic loss-of-function + revertant rescue in mammalian ES cell model, multiple confirmatory cell lines\",\n      \"pmids\": [\"23840637\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"The C-terminal domain of grp94 protects CK2α against thermal aggregation (but not thermal inactivation) in a concentration-dependent manner; disulfide bonds stabilizing grp94 oligomers are required for this chaperone activity.\",\n      \"method\": \"In vitro aggregation assay, DTT reduction, concentration-response analysis\",\n      \"journal\": \"European journal of biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro reconstitution of chaperone protection, disulfide bond dependence shown, single lab\",\n      \"pmids\": [\"11168379\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Structure-guided alanine scanning of the CK2α/CK2β interface identified Leu41 and Phe54 on CK2α as the dominant affinity-determining residues; Ile69 despite its central position contributes modestly; Leu41 and Phe54 mutations are not additive, indicating cooperative action. CK2α mutants retained kinase activity.\",\n      \"method\": \"ITC, alanine scanning mutagenesis, kinase activity assay\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — ITC-guided structure mutagenesis with multiple single and double mutants, rigorous biophysical characterization\",\n      \"pmids\": [\"21142136\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CK2α is required for HPV replication (HPV11, HPV18) in a kinase activity-dependent manner; CK2α regulates stability and nuclear retention of E1 replication proteins of HPV11 and HPV18; CK2α' knockdown does not affect HPV replication, demonstrating isoform specificity.\",\n      \"method\": \"siRNA knockdown of CK2α vs CK2α', HPV replication assays with marker genomes, CX4945 inhibitor, nuclear retention assays\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — siRNA of individual isoforms + pharmacological inhibition + isoform specificity established, multiple orthogonal methods\",\n      \"pmids\": [\"31091289\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The carboxyl-terminal residues 324–328 of CK2α (Xenopus) are essential for catalytic activity; deletion of these residues reduces activity 7000-fold; key residues are Ile327 and Phe324 in helix αN, whose hydrophobic interactions with helix αE (linked to the catalytic center) are required for activity.\",\n      \"method\": \"Deletion mutagenesis, recombinant CK2α kinase activity assay, 3D structural modeling\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro enzymatic mutagenesis with structural interpretation, clear catalytic residue identification\",\n      \"pmids\": [\"12417343\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Fifteen different OCNDS-linked missense mutations in CSNK2A1 (CK2α) lead to varying degrees of reduced kinase activity; some variants also show altered subcellular localization; patient-derived fibroblasts show changes in the phosphoproteome.\",\n      \"method\": \"Recombinant protein kinase activity assay, ectopic expression in mammalian cells, phosphoproteomics, immunofluorescence localization\",\n      \"journal\": \"Human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — biochemical kinase assays on 15 mutants + phosphoproteomics + localization, rigorous multi-method study\",\n      \"pmids\": [\"33944995\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"The OCNDS-associated CK2α Lys198Arg mutation shifts the anion binding site at the P+1 loop (key element of substrate recognition) without affecting CK2β interaction or thermal stability, leading to altered substrate specificity confirmed by enzymological assays.\",\n      \"method\": \"X-ray crystallography, ITC, differential scanning fluorimetry, fluorescence quenching, in vitro kinase assay\",\n      \"journal\": \"Frontiers in molecular biosciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure + multiple biophysical methods + enzymatic data, rigorous structural-functional study\",\n      \"pmids\": [\"35445078\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"A N-terminally deleted form of CK2α' (deleted upstream of Glu-15) is sufficient to support cell viability in CK2α/α'-/- cells; this truncated form co-immunoprecipitates with CK2β and is downregulated by CK2α'-specific siRNA, demonstrating the N-terminal segment regulates CK2α' activity and stability.\",\n      \"method\": \"CRISPR/Cas9 knockout, siRNA, co-immunoprecipitation, in-gel kinase assay, SDS-PAGE\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — CRISPR KO cells + siRNA + co-IP, single lab, mechanistic insight into CK2α' N-terminal regulation\",\n      \"pmids\": [\"32800562\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CK2α interacts with Jak2 and induces phosphorylation and activation of Jak2-Stat3; Stat3 then directly binds the Opa1 promoter to upregulate Opa1 transcription and mitochondrial fusion; CK2α knockdown blunts Jak2-Stat3 phosphorylation and Opa1-mediated fusion.\",\n      \"method\": \"Molecular docking, siRNA knockdown, chromatin immunoprecipitation, pharmacological screening, Western blot\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — siRNA epistasis + ChIP demonstrating Stat3-Opa1 transcription, CK2α-Jak2 interaction based on docking/pharmacology, single lab\",\n      \"pmids\": [\"34418601\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CK2α phosphorylates GRP94 at Ser306, increasing GRP94 stability and enhancing its interaction with LRP6, leading to activation of canonical Wnt signaling and TNBC metastasis.\",\n      \"method\": \"In vitro kinase assay, phosphorylation site identification, co-immunoprecipitation, LRP6 interaction assay, CK2α inhibitor (benzamidine), in vivo metastasis model\",\n      \"journal\": \"Cell death discovery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro kinase assay + co-IP + in vivo model, single lab\",\n      \"pmids\": [\"38649679\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CK2α phosphorylates Mff (mitochondrial fission factor), promoting Drp1 cytoplasmic-to-mitochondrial translocation and mitochondrial fission in cardiac microvascular IR injury.\",\n      \"method\": \"siRNA, phosphorylation assay, Drp1 translocation assay, mitochondrial morphology analysis\",\n      \"journal\": \"Basic research in cardiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — siRNA + phosphorylation assay + subcellular fractionation, single lab\",\n      \"pmids\": [\"29744594\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CSNK2A2 (CK2α') is the paralogous catalytic subunit of protein kinase CK2 that forms holoenzymes with CK2β (with ~12-fold lower affinity than CK2α), is constitutively active, preferentially phosphorylates caspase-3 (an isoform-specific substrate) and BRMS1 (promoting nuclear export and degradation), is required for spermatogenesis via phosphorylation of nuclear proteins in male germ cells, co-operates with CK2α to regulate mitotic progression (through reversible phosphorylation-dependent spindle localization via Pin1), contributes to circadian clock timing by phosphorylating BMAL1 and regulating PER, and can function independently of CK2β to phosphorylate substrates including ribosomal P-proteins; its distinct C-terminal structure and β4/β5 loop conformation relative to CK2α underlie its different CK2β-binding thermodynamics and isoform-specific functions.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"CSNK2A2 encodes CK2\\u03b1', the paralogous catalytic subunit of the constitutively active, acidophilic protein kinase CK2 that recognizes the S/T-D/E-X-D/E consensus and assembles with the CK2\\u03b2 regulatory subunit into a holoenzyme [#11, #2]. CK2\\u03b1' is distinguished from its paralog CK2\\u03b1 at the structural level: a 2\\u00c5 crystal structure shows an open \\u03b24/\\u03b25 loop conformation stabilized by an N-terminal \\u03b2-strand extension and a tryptophan filling a hydrophobic cavity, features that give CK2\\u03b1' ~12-fold lower affinity for CK2\\u03b2 (Kd ~150 nM vs ~13 nM) and underlie its isoform-specific behavior [#2, #10]. These differences translate into distinct substrate selection: CK2\\u03b1' preferentially phosphorylates caspase-3 in cells\\u2014a selectivity abolished by CK2\\u03b2\\u2014and phosphorylates nuclear BRMS1 at Ser30 in response to TNF, triggering 14-3-3\\u03b5-mediated nuclear export and proteasomal degradation that promotes lung cancer metastasis [#4, #5]. CK2\\u03b1' can also act independently of CK2\\u03b2; it was identified as the ribosomal P-protein kinase PK60S and is inhibited by SOD1 [#18]. Genetically, disruption of Csnk2a2 in male mice causes infertility and oligozoospermia with spermatid nuclear abnormalities, loss of nuclear pores, and germ cell death, establishing an essential role in spermatogenesis through phosphorylation of germ-cell nuclear proteins [#3]. CK2\\u03b1' contributes to the mammalian circadian clock\\u2014CK2 phosphorylates BMAL1 at Ser90 to drive nuclear accumulation and clock function, and CK2-mutant cells show lengthened periods [#0, #27]\\u2014and cooperates with CK2\\u03b1 in mitotic regulation, where mitotic phosphorylation of the catalytic subunit directs Pin1-dependent spindle localization [#6, #7]. CK2\\u03b1' is required for cell viability, with dual knockout of both catalytic subunits accelerating CK2\\u03b2 degradation and broadly remodeling the proteome [#26]. Much of the broader CK2 pathway evidence in this corpus derives from the CK2\\u03b1 paralog and concerns shared holoenzyme biology rather than CK2\\u03b1'-specific function.\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Establishing CK2\\u03b1' as a growth-regulated, transformation-competent kinase answered whether the paralog had distinct cellular activity, showing it is a serum-inducible delayed-early gene that cooperates with Ha-ras and phosphorylates calmodulin\\u2014a substrate of free catalytic subunits.\",\n      \"evidence\": \"Northern blot, kinase/foci-formation assays in rat embryo fibroblasts\",\n      \"pmids\": [\"9694889\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not identify physiological substrates driving transformation\", \"Calmodulin phosphorylation reflects free subunit, not holoenzyme, behavior\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"A Csnk2a2 knockout defined the non-redundant in vivo requirement for CK2\\u03b1', revealing an essential role in spermatogenesis via nuclear protein phosphorylation in male germ cells.\",\n      \"evidence\": \"Mouse gene knockout with histology and electron microscopy\",\n      \"pmids\": [\"12950107\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The germ-cell nuclear substrates were not identified\", \"Does not address CK2\\u03b1' function outside the testis\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identification of yeast PK60S as CK2\\u03b1' showed the subunit can act independently of CK2\\u03b2 on ribosomal P-proteins and is subject to SOD1 inhibition, extending its activity beyond holoenzyme contexts.\",\n      \"evidence\": \"Protein purification, peptide mass fingerprinting, kinase and inhibition assays\",\n      \"pmids\": [\"12849977\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab biochemical identification in yeast\", \"Physiological relevance of SOD1 inhibition in human cells unaddressed\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Linking CK2 to BMAL1 Ser90 phosphorylation answered how the kinase feeds into the circadian clock, showing rhythmic phosphorylation is required for nuclear BMAL1 accumulation and clock function.\",\n      \"evidence\": \"siRNA silencing, Ser90 mutagenesis, phosphorylation and nuclear localization assays\",\n      \"pmids\": [\"19330005\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not separate CK2\\u03b1' from CK2\\u03b1 contribution to BMAL1 phosphorylation\", \"Drosophila PER work (PMID 18208335) and ES-cell period studies use the CK2\\u03b1 subunit\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"The 2\\u00c5 CK2\\u03b1' crystal structure with ITC thermodynamics defined the structural basis for its lower CK2\\u03b2 affinity and paralog-specific properties, attributing them to the open \\u03b24/\\u03b25 loop and N-terminal/tryptophan features absent in CK2\\u03b1.\",\n      \"evidence\": \"X-ray crystallography, isothermal titration calorimetry, Michaelis-Menten kinetics\",\n      \"pmids\": [\"21241709\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not map these structural features to specific substrate-selection events\", \"Functional consequences of weaker CK2\\u03b2 binding in cells not directly tested\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Demonstrating caspase-3 as the first cell-based substrate selectively phosphorylated by CK2\\u03b1' answered whether the paralogs differ in cellular substrate choice, with CK2\\u03b2 abolishing the activity.\",\n      \"evidence\": \"siRNA/overexpression of individual subunits, cell-based phosphorylation assays\",\n      \"pmids\": [\"23599180\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Phosphosite on caspase-3 and downstream apoptotic consequence not defined\", \"Single-lab cell-based observation\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Defining the CK2\\u03b1'\\u2013BRMS1 axis explained how the paralog promotes metastasis, showing Ser30 phosphorylation triggers 14-3-3\\u03b5-mediated nuclear export and degradation of the metastasis suppressor.\",\n      \"evidence\": \"In vitro kinase assay, S30A mutagenesis, orthotopic mouse metastasis, co-IP, CX4945\",\n      \"pmids\": [\"26980766\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not establish whether CK2\\u03b1 can substitute for CK2\\u03b1' at this site in vivo\", \"Generality across tumor types beyond lung cancer not tested\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identifying an N-terminally truncated CK2\\u03b1' sufficient for viability defined the N-terminal segment as a regulator of CK2\\u03b1' activity and stability.\",\n      \"evidence\": \"CRISPR knockout cells, siRNA, co-IP, in-gel kinase assay\",\n      \"pmids\": [\"32800562\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which the N-terminus modulates activity not resolved\", \"Single-lab study\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The germ-cell nuclear substrates, the full set of CK2\\u03b1'-selective targets distinguishing it from CK2\\u03b1, and the physiological basis of paralog non-redundancy remain incompletely defined.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No comprehensive CK2\\u03b1'-specific substrate map\", \"Spermatogenesis substrates from the knockout phenotype unidentified\", \"Much pathway-level evidence in the corpus derives from the CK2\\u03b1 paralog, not CK2\\u03b1'\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [4, 5, 18, 11]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [11, 2, 8]},\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [11, 25]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [5, 3]},\n      {\"term_id\": \"GO:0005840\", \"supporting_discovery_ids\": [18]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-9909396\", \"supporting_discovery_ids\": [0, 27]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [5]},\n      {\"term_id\": \"R-HSA-1474165\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"complexes\": [\"CK2 holoenzyme (CK2\\u03b1'/CK2\\u03b2)\"],\n    \"partners\": [\"CSNK2B\", \"BRMS1\", \"CASP3\", \"KIF5C\", \"SOD1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}